logo

Cyclacel Pharmaceuticals Inc. (CYCC)



Trade CYCC now with
  Date
  Headline
7/13/2021 7:25:21 AM Cyclacel Doses First Patient In Phase 1/2 Study Of Oral Fadraciclib In Advanced Solid Tumors And Aggressive Lymphomas
3/12/2021 9:58:30 AM Cyclacel Pharma Prices Underwritten Public Offering Of 1.81 Mln Shares At $7.00/shr
3/12/2021 8:34:32 AM Cyclacel Prices $12.65 Mln Public Offering Of Common Stock
12/21/2020 7:17:24 AM Cyclacel Pharma Announces Election Of Brian Schwartz To Board
9/21/2020 7:09:42 AM Cyclacel Announces Fadraciclib Abstract Selected For Oral Presentation At The 32nd EORTC-NCI-AACR Symposium 2020
4/20/2020 7:11:24 AM Cyclacel Enters Agreement To Study Fadraciclib And Seliciclib